(Q37466936)

20 August 2017

Bioequivalence of HX575 (recombinant human epoetin alfa) and a comparator epoetin alfa after multiple subcutaneous administrations (English)

1 reference

20 August 2017

Fritz Sörgel

1

1 reference

20 August 2017

Ursula Thyroff-Friesinger

2

1 reference

20 August 2017

Andrea Vetter

3

1 reference

20 August 2017

Bernhard Vens-Cappell

4

1 reference

20 August 2017

Martina Kinzig

5

1 reference

20 August 2017

language of work or name

1 reference

22 December 2008

1 reference

20 August 2017

1 reference

20 August 2017

83

1 reference

20 August 2017

2

1 reference

20 August 2017

122-130

1 reference

Correction of the anemia of end-stage renal disease with recombinant human erythropoietin. Results of a combined phase I and II clinical trial

20 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2790786

Erythropoietin and the Control of Red Cell Production

23 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2790786

Anemia of end-stage renal disease (ESRD).

23 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2790786

A distribution-free procedure for the statistical analysis of bioequivalence studies

14 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2790786

Treatment of the anemia of predialysis patients with recombinant human erythropoietin: a randomized, placebo-controlled trial.

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2790786

Randomized, controlled trial of darbepoetin alfa for the treatment of anemia in hemodialysis patients

26 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2790786

Pharmacokinetics and pharmacodynamics of epoetin alfa once weekly and three times weekly

2 September 2018

1 reference

12 December 2020

A safety and efficacy comparison study of two dosing regimens of epoetin alfa in patients undergoing major orthopedic surgery

1 reference

12 December 2020

Recombinant human erythropoietin in anemic patients with end-stage renal disease. Results of a phase III multicenter clinical trial

1 reference

12 December 2020

The quality of life of hemodialysis recipients treated with recombinant human erythropoietin. Cooperative Multicenter EPO Clinical Trial Group

1 reference

12 December 2020

The effects of recombinant human erythropoietin on perioperative transfusion requirements in patients having a major orthopaedic operation. The American Erythropoietin Study Group

1 reference

12 December 2020

Baseline hemoglobin as a predictor of risk of transfusion and response to Epoetin alfa in orthopedic surgery patients

1 reference

12 December 2020

Recombinant human erythropoietin treatment in pre-dialysis patients. A double-blind placebo-controlled trial

1 reference

12 December 2020

Identifiers

DOI

10.1159/000189027

1 reference

20 August 2017

1 reference

20 August 2017

PubMed publication ID

19122476

1 reference